SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
CONCLUSIONS: This is the first report of severe acute respiratory syndrome coronavirus 2-associated HLH. Identification of HLH in a subset of patients with severe COVID-19 will inform clinical trials of therapeutic strategies.
PMID: 32681166 [PubMed - as supplied by publisher]
Source: American Journal of Clinical Pathology - Category: Pathology Authors: Prilutskiy A, Kritselis M, Shevtsov A, Yambayev I, Vadlamudi C, Zhao Q, Kataria Y, Sarosiek SR, Lerner A, Sloan JM, Quillen K, Burks EJ Tags: Am J Clin Pathol Source Type: research
More News: Clinical Trials | Coronavirus | COVID-19 | Laboratory Medicine | Liver | Pathology | Respiratory Medicine | SARS | Urology & Nephrology